Early completion based on multiple dosages to accelerate maximum tolerated dose-finding

by   Masahiro Kojima, et al.

Background: Phase I trials desire to identify the maximum tolerated dose (MTD) early and proceed quickly to an expansion cohort or phase II trial for efficacy. We propose an early completion method based on multiple dosages to accelerate the identification of MTD for model-assisted designs. Methods: The early completion performs based on each dose-assignment probability for multiple dosages. The formulas of probabilities are simple to calculate. We evaluated the early completion for an actual trial. In addition, a simulation study performed the percentage of correct MTD selection and early completion. Results: In the actual trial, the early completion could perform, and the MTD estimation phase could be shortened. In the simulation study, the change in the percentage of correct MTD selection from non-early completion version was 2.2 at the maximum, indicating that there was almost no decrease. In addition, depending on the toxicity rate, the percentage of correct MTD selection improved compared to the non-early completion version. The early completion performed from 18.1 method with not only little reduction in accuracy but also improving the percentage of correct MTD selection. We conclude the early completion can perform unproblematically for model-assisted design.


Adaptive design for identifying maximum tolerated dose early to accelerate dose-finding trial

Purpose: The early identification of maximum tolerated dose (MTD) in pha...

Data-Dependent Early Completion of Dose Finding Trials for Drug-Combination

We propose a data-dependent early completion of dose finding trials for ...

Adaptive Cohort Size Determination Method for Bayesian Optimal Interval Phase I/II Design to Shorten Clinical Trial Duration

Recently, the strategy for dose optimization in oncology has shifted to ...

Bayesian model for early dose-finding in phase I trials with multiple treatment courses

Dose-finding clinical trials in oncology aim to determine the maximum to...

Dose Finding Studies for Therapies with Late-Onset Toxicities: A Comparison Study of Designs

An objective of phase I dose-finding trials is to find the maximum toler...

Introduction of accelerated BOIN design and facilitation of its application

Purpose: During discussions at the Data Science Roundtable meeting in Ja...

Please sign up or login with your details

Forgot password? Click here to reset